This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Steven M. Hacker, MD
Division of Dermatology and Cutaneous Surgery Department of Medicine University of Florida College of Medicine PO Box 100277 Gainesville, FL 32610-0277

I. Keith Stone, MD; Franklin P. Flowers, MD
Gainesville, Fla

Arch Dermatol. 1994;130(11):1454-1455.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Morphea and lichen sclerosus et atrophicus (LSA) are two cutaneous disorders with an unclear cause. The two disorders have been reported to occur in the same patient.^1,2 Thus, a common link has been proposed. However, Patterson and Ackerman³ feel that morphea and LSA are two unrelated, distinct diseases.

The most frequent specific anti-nuclear antibodies in localized scleroderma are anti-single-stranded (ss) DNA antibodies. The reported prevalence ranges from 38% to 75% of cases.^4,5 The anti-ss DNA antibodies are observed with greater frequency in generalized morphea and linear scleroderma, especially in active or extensive cases, compared with morphea. Nonetheless, even morphea revealed a prevalence of anti-ss DNA antibodies in 27% of the cases studied recently.⁴ Because of the prevalence of this antibody in localized scleroderma, we decided to study the frequency of this antibody in LSA.

Patients and Methods.

Six patients with clinical and histologic evidence of vulvar . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?